Published in J Virol on March 01, 2003
Selective replication of coronavirus genomes that express nucleocapsid protein. J Virol (2005) 1.44
Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3. J Virol (2008) 1.27
A major determinant for membrane protein interaction localizes to the carboxy-terminal domain of the mouse coronavirus nucleocapsid protein. J Virol (2005) 1.23
Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent. J Virol (2005) 1.21
Severe acute respiratory syndrome coronavirus 7a accessory protein is a viral structural protein. J Virol (2006) 1.18
Ribonucleocapsid formation of severe acute respiratory syndrome coronavirus through molecular action of the N-terminal domain of N protein. J Virol (2007) 1.18
Severe acute respiratory syndrome coronavirus accessory protein 6 is a virion-associated protein and is released from 6 protein-expressing cells. J Virol (2007) 1.10
Multigene RNA vector based on coronavirus transcription. J Virol (2003) 1.03
Cryo-electron tomography of mouse hepatitis virus: Insights into the structure of the coronavirion. Proc Natl Acad Sci U S A (2009) 1.02
Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV. Vaccine (2007) 0.97
The coronavirus nucleocapsid is a multifunctional protein. Viruses (2014) 0.95
Transmissible gastroenteritis coronavirus packaging signal is located at the 5' end of the virus genome. J Virol (2003) 0.91
A structural analysis of M protein in coronavirus assembly and morphology. J Struct Biol (2010) 0.90
Importance of the penultimate positive charge in mouse hepatitis coronavirus A59 membrane protein. J Virol (2007) 0.89
Coronavirus spike glycoprotein, extended at the carboxy terminus with green fluorescent protein, is assembly competent. J Virol (2004) 0.89
Differential stepwise evolution of SARS coronavirus functional proteins in different host species. BMC Evol Biol (2009) 0.87
The structure and functions of coronavirus genomic 3' and 5' ends. Virus Res (2015) 0.87
Functional analysis of the murine coronavirus genomic RNA packaging signal. J Virol (2013) 0.86
Self-assembly of severe acute respiratory syndrome coronavirus membrane protein. J Biol Chem (2010) 0.85
New structure model for the packaging signal in the genome of group IIa coronaviruses. J Virol (2007) 0.85
The nsp1, nsp13, and M proteins contribute to the hepatotropism of murine coronavirus JHM.WU. J Virol (2015) 0.83
Interaction of the coronavirus infectious bronchitis virus membrane protein with beta-actin and its implication in virion assembly and budding. PLoS One (2009) 0.82
Recognition of the murine coronavirus genomic RNA packaging signal depends on the second RNA-binding domain of the nucleocapsid protein. J Virol (2014) 0.78
Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum. Eur J Clin Microbiol Infect Dis (2005) 0.75
A key role for the carboxy-terminal tail of the murine coronavirus nucleocapsid protein in coordination of genome packaging. Virology (2016) 0.75
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 32.58
RNA of mouse hepatitis virus. J Virol (1978) 4.27
Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs. J Virol (1993) 4.19
The budding mechanisms of enveloped animal viruses. J Gen Virol (1980) 4.08
Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid. J Virol (1980) 3.82
Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. Proc Natl Acad Sci U S A (1984) 3.81
RNA replication of mouse hepatitis virus takes place at double-membrane vesicles. J Virol (2002) 3.69
RNA is a structural element in retrovirus particles. Proc Natl Acad Sci U S A (2001) 3.45
Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. EMBO J (1996) 3.33
Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch Gesamte Virusforsch (1974) 3.24
Sequence and topology of a model intracellular membrane protein, E1 glycoprotein, from a coronavirus. Nature (1984) 3.15
Coronavirus mRNA synthesis involves fusion of non-contiguous sequences. EMBO J (1983) 3.13
Spike protein-nucleocapsid interactions drive the budding of alphaviruses. J Virol (1992) 2.91
Replication of coronavirus MHV-A59 in sac- cells: determination of the first site of budding of progeny virions. Eur J Cell Biol (1984) 2.61
Nucleocapsid-glycoprotein interactions required for assembly of alphaviruses. J Virol (1994) 2.47
Tunicamycin resistant glycosylation of coronavirus glycoprotein: demonstration of a novel type of viral glycoprotein. Virology (1981) 2.34
A system for study of coronavirus mRNA synthesis: a regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion. J Virol (1991) 2.30
Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding. J Virol (1994) 2.27
Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effect of tunicamycin. J Virol (1981) 2.27
The production of recombinant infectious DI-particles of a murine coronavirus in the absence of helper virus. Virology (1996) 2.15
A domain at the 3' end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs. J Virol (1991) 2.14
Analysis of genomic and intracellular viral RNAs of small plaque mutants of mouse hepatitis virus, JHM strain. Virology (1984) 2.13
Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA. Cell (1994) 2.08
Analysis of constructed E gene mutants of mouse hepatitis virus confirms a pivotal role for E protein in coronavirus assembly. J Virol (1998) 2.05
Identification and characterization of a coronavirus packaging signal. J Virol (1992) 2.01
Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription. J Virol (1988) 2.00
Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells. J Virol (2000) 1.89
Defective-interfering particles of murine coronavirus: mechanism of synthesis of defective viral RNAs. Virology (1988) 1.73
The membrane M protein carboxy terminus binds to transmissible gastroenteritis coronavirus core and contributes to core stability. J Virol (2001) 1.71
Mouse hepatitis virus gene 5b protein is a new virion envelope protein. Virology (1994) 1.70
Genetic evidence for a structural interaction between the carboxy termini of the membrane and nucleocapsid proteins of mouse hepatitis virus. J Virol (2002) 1.69
Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology (1989) 1.66
Cooperation of an RNA packaging signal and a viral envelope protein in coronavirus RNA packaging. J Virol (2001) 1.56
Release of coronavirus E protein in membrane vesicles from virus-infected cells and E protein-expressing cells. Virology (1999) 1.39
Oligomerization of a trans-Golgi/trans-Golgi network retained protein occurs in the Golgi complex and may be part of its retention. J Biol Chem (1995) 1.30
Mouse hepatitis virus replicase protein complexes are translocated to sites of M protein accumulation in the ERGIC at late times of infection. Virology (2001) 1.29
Role of cell surface spikes in alphavirus budding. J Virol (1992) 1.20
Assembled coronavirus from complementation of two defective interfering RNAs. J Virol (1997) 1.18
Murine coronavirus packaging signal confers packaging to nonviral RNA. J Virol (1997) 1.13
Acquired fusion activity of a murine coronavirus MHV-2 variant with mutations in the proteolytic cleavage site and the signal sequence of the S protein. Virology (1997) 1.11
Replication of murine coronavirus defective interfering RNA from negative-strand transcripts. J Virol (1996) 0.87
Gene expression analysis of zebrafish heart regeneration. PLoS Biol (2006) 3.00
Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol (2006) 2.73
Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods (2009) 2.64
fgf20 is essential for initiating zebrafish fin regeneration. Science (2005) 2.43
Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation. Proc Natl Acad Sci U S A (2006) 2.31
Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog (2009) 2.17
Sema3a maintains normal heart rhythm through sympathetic innervation patterning. Nat Med (2007) 2.16
The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly. J Virol (2006) 2.07
Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun (2008) 2.04
The pathogenesis of Rift Valley fever. Viruses (2011) 2.02
Uric acid promotes an acute inflammatory response to sterile cell death in mice. J Clin Invest (2010) 1.97
NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis. J Virol (2007) 1.94
Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system. J Virol (2005) 1.90
NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. J Virol (2006) 1.81
Nerve growth factor is critical for cardiac sensory innervation and rescues neuropathy in diabetic hearts. Circulation (2006) 1.76
Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment. J Virol (2005) 1.72
Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. J Virol (2008) 1.69
Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein. J Virol (2005) 1.64
Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor. J Virol (2006) 1.49
Intramolecular control of protein stability, subnuclear compartmentalization, and coactivator function of peroxisome proliferator-activated receptor gamma coactivator 1alpha. J Biol Chem (2007) 1.49
Rift valley fever vaccines. Vaccine (2009) 1.47
A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein. Nat Struct Mol Biol (2009) 1.42
Natural endogenous adjuvants. Springer Semin Immunopathol (2004) 1.34
Murine coronavirus replication-induced p38 mitogen-activated protein kinase activation promotes interleukin-6 production and virus replication in cultured cells. J Virol (2002) 1.27
Nucleotide sequence requirements at the 5' end of the influenza A virus M RNA segment for efficient virus replication. J Virol (2009) 1.26
Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR. Ann N Y Acad Sci (2009) 1.24
Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication. J Virol (2005) 1.22
Characterization of tumor imaging with microbubble-based ultrasound contrast agent, sonazoid, in rabbit liver. Biol Pharm Bull (2005) 1.19
Bone marrow-derived regenerated cardiomyocytes (CMG Cells) express functional adrenergic and muscarinic receptors. Circulation (2002) 1.19
Severe acute respiratory syndrome coronavirus 7a accessory protein is a viral structural protein. J Virol (2006) 1.18
SARS coronavirus nsp1 protein induces template-dependent endonucleolytic cleavage of mRNAs: viral mRNAs are resistant to nsp1-induced RNA cleavage. PLoS Pathog (2011) 1.17
Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection. J Immunol (2005) 1.16
Bone marrow derived cells are involved in the pathogenesis of cardiac hypertrophy in response to pressure overload. Circulation (2007) 1.10
Murine coronavirus replication induces cell cycle arrest in G0/G1 phase. J Virol (2004) 1.10
Severe acute respiratory syndrome coronavirus accessory protein 6 is a virion-associated protein and is released from 6 protein-expressing cells. J Virol (2007) 1.10
Characterization of N protein self-association in coronavirus ribonucleoprotein complexes. Virus Res (2003) 1.09
Characterization of Rift Valley fever virus transcriptional terminations. J Virol (2007) 1.06
Rapid accumulation of virulent rift valley Fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the m RNA. PLoS One (2010) 1.05
Mechanism of tripartite RNA genome packaging in Rift Valley fever virus. Proc Natl Acad Sci U S A (2010) 1.02
G-CSF influences mouse skeletal muscle development and regeneration by stimulating myoblast proliferation. J Exp Med (2011) 1.02
Glycosylation of the West Nile Virus envelope protein increases in vivo and in vitro viral multiplication in birds. Am J Trop Med Hyg (2010) 1.02
SARS coronavirus accessory proteins. Virus Res (2007) 1.01
Murine coronavirus nonstructural protein p28 arrests cell cycle in G0/G1 phase. J Virol (2004) 1.01
Rapid phosphoproteomic and transcriptomic changes in the rhizobia-legume symbiosis. Mol Cell Proteomics (2012) 1.00
Murine coronavirus-induced apoptosis in 17Cl-1 cells involves a mitochondria-mediated pathway and its downstream caspase-8 activation and bid cleavage. Virology (2002) 1.00
Severe acute respiratory syndrome coronavirus 3a protein is released in membranous structures from 3a protein-expressing cells and infected cells. J Virol (2006) 1.00
Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep. Vaccine (2012) 0.99
Suppression of host gene expression by nsp1 proteins of group 2 bat coronaviruses. J Virol (2009) 0.98
Bacterial infection in association with snakebite: a 10-year experience in a northern Taiwan medical center. J Microbiol Immunol Infect (2011) 0.98
Hyperthermia inhibits homologous recombination repair and sensitizes cells to ionizing radiation in a time- and temperature-dependent manner. J Cell Physiol (2013) 0.98
Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV. Vaccine (2007) 0.97
Rift valley fever virus L protein forms a biologically active oligomer. J Virol (2009) 0.96
The C-terminal region of Rift Valley fever virus NSm protein targets the protein to the mitochondrial outer membrane and exerts antiapoptotic function. J Virol (2012) 0.96
Comparison of cellular lethality in DNA repair-proficient or -deficient cell lines resulting from exposure to 70 MeV/n protons or 290 MeV/n carbon ions. Oncol Rep (2012) 0.95
Neural crest-derived stem cells migrate and differentiate into cardiomyocytes after myocardial infarction. Arterioscler Thromb Vasc Biol (2011) 0.95
Omentopexy enhances graft function in myocardial cell sheet transplantation. Biochem Biophys Res Commun (2009) 0.94
miR-142-3p is essential for hematopoiesis and affects cardiac cell fate in zebrafish. Biochem Biophys Res Commun (2012) 0.93
Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves. Vaccine (2013) 0.92
Genetic analysis of essential cardiac transcription factors in 256 patients with non-syndromic congenital heart defects. Circ J (2012) 0.91
Zac1 is an essential transcription factor for cardiac morphogenesis. Circ Res (2010) 0.91
Gray-scale liver enhancement with Sonazoid (NC100100), a novel ultrasound contrast agent; detection of hepatic tumors in a rabbit model. Biol Pharm Bull (2003) 0.90
Review of diagnostic plaque reduction neutralization tests for flavivirus infection. Vet J (2012) 0.90
A structural analysis of M protein in coronavirus assembly and morphology. J Struct Biol (2010) 0.90
Application of mesenchymal stem cell-derived cardiomyocytes as bio-pacemakers: current status and problems to be solved. Med Biol Eng Comput (2007) 0.90
Interplay between viruses and host mRNA degradation. Biochim Biophys Acta (2012) 0.90
Wnt2 accelerates cardiac myocyte differentiation from ES-cell derived mesodermal cells via non-canonical pathway. J Mol Cell Cardiol (2011) 0.90
Epizootiological study of tick-borne encephalitis virus infection in Japan. J Vet Med Sci (2010) 0.90
Brain abscesses in children: analysis of 20 cases presenting at a medical center. J Microbiol Immunol Infect (2008) 0.87
Gene knock-outs of inositol 1,4,5-trisphosphate receptors types 1 and 2 result in perturbation of cardiogenesis. PLoS One (2010) 0.87
Establishment of a neutralization test involving reporter gene-expressing virus-like particles of tick-borne encephalitis virus. J Virol Methods (2009) 0.86
Roles of the coding and noncoding regions of rift valley Fever virus RNA genome segments in viral RNA packaging. J Virol (2012) 0.86
Cyclosporin A inhibits the replication of diverse coronaviruses. J Gen Virol (2011) 0.86
Polysaccharides purified from the submerged culture of Ganoderma formosanum stimulate macrophage activation and protect mice against Listeria monocytogenes infection. Biotechnol Lett (2011) 0.86
Severe acute respiratory syndrome coronavirus protein nsp1 is a novel eukaryotic translation inhibitor that represses multiple steps of translation initiation. J Virol (2012) 0.86
2-(3-Fluorophenyl)-6-methoxyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (YJC-1) induces mitotic phase arrest in A549 cells. Eur J Pharmacol (2006) 0.85
Characterization of synthetic Chikungunya viruses based on the consensus sequence of recent E1-226V isolates. PLoS One (2013) 0.84
Characteristics and outcome of septic arthritis in children. J Microbiol Immunol Infect (2006) 0.84
Application of a molecular method for the classification of human enteroviruses and its correlation with clinical manifestations. J Microbiol Immunol Infect (2010) 0.83
Headache in late pregnancy: a symptom for Vogt-Koyanagi-Harada disease. Arch Gynecol Obstet (2010) 0.83
Two identical nonylphenol monooxygenase genes linked to IS6100 and some putative insertion sequence elements in Sphingomonas sp. NP5. Microbiology (2012) 0.83
Extracellular polysaccharides produced by Ganoderma formosanum stimulate macrophage activation via multiple pattern-recognition receptors. BMC Complement Altern Med (2012) 0.83
Glycogen synthase kinase 3 negatively regulates IFN regulatory factor 3 transactivation through phosphorylation at its linker region. Innate Immun (2013) 0.82
Phenotype of DFNA11: a nonsyndromic hearing loss caused by a myosin VIIA mutation. Laryngoscope (2002) 0.82
Epigenetic control of cardiomyocyte production in response to a stress during the medaka heart development. Dev Biol (2010) 0.82
A PCR-based protocol for the generation of a recombinant West Nile virus. Virus Res (2009) 0.82
Interplay between the Virus and Host in Rift Valley Fever Pathogenesis. J Innate Immun (2015) 0.81
Involvement of hepatocellular carcinoma biomarker, cyclase-associated protein 2 in zebrafish body development and cancer progression. Exp Cell Res (2012) 0.81
A high prevalence of autoimmune indices and disorders in primary nummular headache. J Neurol Sci (2012) 0.81
The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responses. PLoS One (2013) 0.80
1-(3,4-dimethoxyphenyl)-3,5-dodecenedione (I6) induces G1 arrest and apoptosis in human promyelocytic leukemia HL-60 cells. Leuk Res (2005) 0.80
Characterization of the RNA-binding protein Musashi1 in zebrafish. Brain Res (2012) 0.80
2-(3-Methoxyphenyl)-5-methyl-1,8-naphthyridin-4(1H)-one (HKL-1) induces G2/M arrest and mitotic catastrophe in human leukemia HL-60 cells. Toxicol Appl Pharmacol (2012) 0.79
[Rift Valley fever virus]. Uirusu (2004) 0.79
Infectious endocarditis in pediatric patients: analysis of 19 cases presenting at a medical center. J Microbiol Immunol Infect (2010) 0.79
Common marmoset embryonic stem cell can differentiate into cardiomyocytes. Biochem Biophys Res Commun (2008) 0.78
Activation of antitumor immune responses by Ganoderma formosanum polysaccharides in tumor-bearing mice. Appl Microbiol Biotechnol (2014) 0.78
Simple autogeneic feeder cell preparation for pluripotent stem cells. Stem Cell Res (2010) 0.77
Subcutaneously implanted central venous access device infection in pediatric patients with cancer. J Microbiol Immunol Infect (2009) 0.77